INVESTIGATING THE PROGNOSTIC SIGNIFICANCE OF MICRORNA-335 EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Joanne Shu Xian Lee, 99705

IDENTIFICATION OF DISTINCT PROGNOSTIC SUBGROUPS IN HIGH-HYPERDIPLOID PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA BY MULTI-TARGET INTERPHASE FISH

EHA Library, Agnes Vojcek, 99706

EARLY CLEARING OF PERIPHERAL BLOOD BLASTS IS AN INDEPENDENT PROGNOSTIC FACTOR IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Juliana Schuh, 99707

PHILADELPHIA CHROMOSOME MAY NOT BE AN ADVERSE PROGNOSTIC FACTOR IN THE OLD-AGE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS IN THE ERA OF TYROSINE KINASE INHIBITOR

EHA Library, Jung YeonLee, 99708

LYMPHOMA SURVIVORSHIP AND CARDIOVASCULAR DISEASES: DETECTION OF EARLY CARDIAC DYSFUNCTION

EHA Library, Maria Pina Simula, 99709

LACK OF PROGNOSTIC IMPACT OF ABERRANT MYELOID ANTIGEN EXPRESSION IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Mafalda Alpoim Vieira, 99710

OUTCOME OF OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH HYPERCVAD

EHA Library, Juliana Schuh, 99711

INHIBITION OF AXL KINASE SUPPRESSES RETINOIC ACID METABOLISM THROUGH REGULATION OF CYP26

EHA Library, Clifford Whatcott, 99712

AN EFFICIENT COMPUTATIONAL APPROACH TO EVALUATE THE EXPRESSION PROFILE OF INDIVIDUAL ACUTE LEUKEMIA PATIENTS

EHA Library, Marcus Hansen, 99713

B-CELL CLONALITY IN BONE MARROW IS PREDICTOR OF OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH HIGH-DOSE CHEMOTHERAPY.

EHA Library, Olga Aleshina Gavrilina, 99715

AKT GENE EXPRESSION IS REGULATED BY THE AP-1 TRANSCRIPTION FACTORS JUNB AND CJUN IN ALK+ ANAPLASTIC LARGE CELL LYMPHOMA (ALCL): A NOVEL CROSSTALK MECHANISM

EHA Library, George Rassidakis, 99716

COMBINED INHIBITION OF HEDGEHOG AND FLT3 SIGNALLING LEADS TO EFFECTIVE ANTI-LEUKEMIC EFFECTS IN ACUTE MYELOID LEUKEMIA

EHA Library, Emily Latuske, 99717

MOLECULAR DIAGNOSIS BY GENE EXPRESSION PROFILING IN FORMALIN FIXED PARAFFIN EMBEDDED TISSUE - BURKITT LYMPHOMAS WITH EXPRESSION OF BCL2

EHA Library, Neus Masqué-Soler, 99718

CLINICAL CHARACTERISTICS AND PROGNOSTIC IMPLICATIONS OF DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA

EHA Library, Ekaterina Motyko, 99719

CRITICAL ROLE OF SOX12 IN LEUKEMOGENESIS IN AML

EHA Library, Haixia Wan, 99720

NFKBIE MUTATIONS OCCUR IN 15% OF GCB DLBCL AND IN VARIOUS OTHER LYMPHOID MALIGNANCIES.

EHA Library, Daniel Noerenberg, 99721

IMPACT OF DEVELOPMENTAL STAGE AND AGE ON GENE EXPRESSION IN CHILDHOOD AND ADULT ACUTE MYELOID LEUKAEMIA

EHA Library, Adam Stevens, 99722

EVALUATION OF GENOMIC IMBALANCES AND MIRNA EXPRESSION IN PATIENTS WITH MYCOSIS FUNGOIDES

EHA Library, Fuad Huaman Garaicoa, 99723

MULTIPLE INJECTIONS OF ANTIBODY-RADIONUCLIDE-CONJUTAGES TARGETING CD37 INCREASES TOLERABILITY IN NUDE MICE BEARING NON-HODGKIN LYMPHOMA XENOGRAFTS

EHA Library, Helen Heyerdahl, 99724

IMMUNOPHENOTYPIC CHARACTERIZATION AND CLINICAL BEHAVIOUR IN CD19+CD5+ (NON-CLL) LYMPHOPROLIFERATIVE DISORDERS MUTATED AND UNMUTATED WITH AND WITHOUT T(11,14)

EHA Library, Lucia Lopez-Anglada Fernandez, 99725

ROLE OF DNMT3A MUTATIONS IN INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA PATIENTS: ASSOCIATION WITH PROGNOSIS AND TREATMENT STRATEGIES.

EHA Library, Isabel Prieto-Conde, 99726

ACUTE MYELOID LEUKEMIA DISEASE MODELING VIA RNA-GUIDED CRISPR–CAS9 SYSTEM INDUCED SOMATIC MUTATIONS

EHA Library, Oliver Brabetz, 99727

THE IMPACT OF MUTATION STATUS OF SOCS1 IN PATIENTS WITH HIGH-GRADE DIFFUSE LARGE B-CELL LYMPHOMA.

EHA Library, Olga Aleshina Gavrilina, 99728

THE PI3K GAMMA/DELTA INHIBITOR, IPI-145 (DUVELISIB) INHIBITS ACUTE MYELOID LEUKEMIA BLAST PROLIFERATION AND ADHESION

EHA Library, Genevra Pillinger, 99729

INTERIM ANALYSIS OF A PHASE 1B STUDY EVALUATING THE SAFETY OF GS-9820, A SECOND-GENERATION PI3K DELTA-INHIBITOR, IN RELAPSED/REFRACTORY LYMPHOID MALIGNANCIES

EHA Library, Arnon Kater, 99730

NON-GASTRIC MALT LYMPHOMAS (NG-MALT). CLINICAL CHARACTERISTICS AND OUTCOME IN A SERIES OF 185 PATIENTS: ASSESSING PARAMETERS OF PROGNOSTIC SIGNIFICANCE

EHA Library, Christina Kalpadakis, 99731

PHARMACOKINETIC DATA, CLINICAL CHARACTERISTICS AND OUTCOME IN FOLLICULAR LYMPHOMA PATIENTS IN MAINTENANCE WITH RITUXIMAB: AN ANALYSIS OF THE FONDAZIONE ITALIANA LINFOMI (FIL)

EHA Library, Alice Di ROCCO, 99733

THE EXPRESSION OF THE DNA REPAIR GENE SETMAR IS HIGHLY CORRELATED TO THE LEVEL OF THE MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA THROUGHOUT THE DISEASE.

EHA Library, Julie Jensen, 99734

CORRELATION OF GENOMIC ANALYSIS BY MYAML™ WITH IN VITRO HIGH THROUGHPUT DRUG SENSITIVITY TESTING IN NEW DIAGNOSIS AND RELAPSED ACUTE MYELOID LEUKEMIA

EHA Library, Pamela Becker, 99735

EXPOSURE TO ROS INDUCES DNA DAMAGE AND INFLUENCES DNA METHYLATION IN NORMAL AND MALIGNANT HEMATOLOGICAL CELL LINES

EHA Library, Ana Cristina Gonçalves, 99736

POLYMORPHISM OF FOLATE AND METHIONINE METABOLISM GENES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME

EHA Library, Zhanna Sidorova, 99737

STUDY OF PLASMA ENDOSTATIN LEVEL IN PATIENTS WITH ‎ACUTE MYELOID LEUKEMIA

EHA Library, Rasha Haggag, 99738

IMPACT OF CYTOGENETICS ON CLINICAL OUTCOME IN PATIENTS WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA TREATED WITH VOSAROXIN PLUS CYTARABINE VS PLACEBO PLUS CYTARABINE: RESULTS FROM VALOR

EHA Library, Norbert Vey, 99739

IDH1 (BUT NOT IDH2) MUTATIONS CAUSE INFERIOR OUTCOME IN PATIENTS WITH AML WITH AN INTERMEDIATE-RISK CYTOGENETICS

EHA Library, Jana Marková, 99740

CHARACTERISTICS OF ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH GATA2 MUTATIONS

EHA Library, Hoyoung Maeng, 99741

DAY-14 LAIP ON BONE MARROW PREDICTS COMPLETE RESPONSE AND DRIVE EARLY SALVAGE CHEMOTHERAPY IN AML: RESULTS OF MULTIPARAMETER FLOW CYTOMETRY AND WT1-RNA QUANTIFICATION.

EHA Library, Carlo Messina, 99742

LONG-TERM REPORT OF A PILOT STUDY EVALUATING CLOFARABINE COMBINED WITH INTERMEDIATE-DOSE CYTARABINE AS CONSOLIDATION THERAPY IN PATIENTS WITH NON-FAVORABLE ACUTE MYELOID LEUKEMIA IN FIRST REMISSION.

EHA Library, Louise Roulin, 99743

RETRO-TRANSCRIPTION LOOP MEDIATED ISOTHERMAL AMPLIFICATION (RT-Q-LAMP) AS A RAPID AND ROBUST MOLECULAR ASSAY FOR THE DIAGNOSTIC DETECTION OF PML-RARA FUSION TRANSCRIPTS

EHA Library, Maria Domenica Divona, 99744

THE ROLE OF AZACITIDINE IN THE TREATMENT OF ELDERLY PATIENTS WITH AML - RESULTS OF A RETROSPECTIVE MULTICENTER STUDY

EHA Library, Anil Tombak, 99745

AZACYTIDINE THERAPY IN PREVIOUSLY UNTREATED ELDERLY AML PATIENTS: COMPARISON WITH CONVENTIONAL CHEMOTHERAPY IN A MATCHED-PAIRED ANALYSIS

EHA Library, Paola Minetto, 99746

PROGNOSTIC IMPACT OF WT1 GENE EXPRESSION QUANTIFICATION DURING MINIMAL RESIDUAL DISEASE MONITORING OF ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mirjana Mitrovic, 99747

CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: RISK FACTORS, TREATMENT AND OUTCOME

EHA Library, Irena Djunic, 99748

PHASE 1 STUDY: SAFETY AND TOLERABILITY OF INCREASING DOSES OF CB-839, AN ORALLY-ADMINISTERED SMALL MOLECULE INHIBITOR OF GLUTAMINASE, IN ACUTE LEUKEMIA

EHA Library, Marina Y.Konopleva, 99749

R-DA-EPOCH VS R-CHOP IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: INTERIM RESULTS OF RANDOMIZED (PROSPECTIVE) MULTICENTER STUDY

EHA Library, Iryna Kriachok, 99750

REDUCED MEDICAL COSTS AND HOSPITAL DAYS WITH ORAL ARSENIC PLUS RETINOIC ACID COMPARED WITH INTRAVENOUS ARSENIC PLUS RETINOIC ACID AS THE FRONT-LINE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Xiangyu Zhao, 99751

PROPOSED PROGNOSTIC MODEL FOR PERIPHERAL T-CELL LYMPHOMA: PSU-PROGNOSTIC INDEX FOR T-CELL LYMPHOMA (PSU-PIT) SCORE

EHA Library, Jakrawadee Julamanee, 99752

A PHASE IB/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF VISMODEGIB IN RELAPSED/REFRACTORY ACUTE MYELOGENOUS LEUKEMIA

EHA Library, Richard Noppeney, 99753

PHASE I/II STUDY OF DFP-10917 GIVEN BY CONTINUOUS INFUSION IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LEUKEMIA: PHARMACOKINETIC, PHARMACODYNAMICS AND PHARMACOGENOMICS PROPERTIES.

EHA Library, William Plunkett, 99754

PROSPECTIVE PHASE II TRIAL OF LENALIDOMIDE IN ASSOCIATION WITH CHOP IN ELDERLY PATIENTS WITH ANGIOIMMUNOBLASTIC T CELL LYMPHOMA (AITL): INTERIM ANALYSIS OF A LYSA STUDY.

EHA Library, Violaine Safar, 99755

SUVMAX ON 18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY SCAN IS ASSOCIATED WITH CLINICOPATHOLOGICAL FACTORS AND PROGNOSIS IN NEWLY DIAGNOSED PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Hong-Hui Huang, 99756

PROGNOSTIC VALUE OF INTERIM POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY IN 377 PATIENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTIONAL ANALYSIS OVER THE 8 YEARS

EHA Library, Kota Fukumoto, 99757

HIGH-THROUGHPUT SEQUENCING OF BOTH IMMUNOGLOBULIN LIGHT AND HEAVY CHAIN GENE REARRANGEMENTS IMPROVES DETECTION OF NEOPLASTIC CLONES IN MATURE B-CELL LYMPHOMAS

EHA Library, Anna Sherwood, 99758

AN INHERITED MUTATION OF THE NOD2 GENE IS ASSOCIATED WITH POOR SURVIVAL OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA.

EHA Library, Magdalena Zawartko, 99760

MYC/BCL2 DOUBLE EXPRESSION INCREASES A RISK OF RELAPSE OR PROGRESSION IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY M-NHL-BFM-90 PLUS RITUXIMAB

EHA Library, Anna Misyurina, 99761

CLINICAL FEATURES AND OUTCOMES OF PATIENTS WITH EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE: A PROSPECTIVE MULTICENTER STUDY FROM THE THAI LYMPHOMA REGISTRY

EHA Library, Tawatchai Suwanban, 99762

CD30 EXPRESSION IN DE NOVO DIFFUSE LARGE B-CELL LYMPHOMA: CLINICAL FEATURES AND OUTCOME

EHA Library, Francesco Gaudio, 99763

PHASE II STUDY OF SMILE CHEMOTHERAPY FOR RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA

EHA Library, Ritsuro Suzuki, 99764

HUMAN T-LYMPHOTROPIC VIRUS TYPE I TAX SPECIFIC CYTOTOXIC T-LYMPHOCYTE ANALYSIS OF AGGRESSIVE TYPES OF ADULT T-CELL LEUKEMIA/LYMPHOMA PATIENTS WITH LONG-TERM SURVIVAL AND COMPLETE REMISSION

EHA Library, Tatsuro Jo, 99765

PROPHYLACTIC USE OF ACETAZOLAMIDE REDUCES WEIGHT GAIN AND AMELIORATES RENAL COMPLICATIONS ASSOCIATED WITH HIGH DOSE METHOTREXATE

EHA Library, Matthew Ku, 99766

PROPOSAL OF NEW PROGNOSTIC INDEX FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA

EHA Library, Shinkyo Yoon, 99767

AN INVESTIGATION OF RADIATION THERAPY FOR DLBCL AFTER CHEMOTHERAPY FOR ACHIEVING COMPLETE REMISSION: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Aya Ouchi, 99768

UNDERWEIGHT AND LOW BODY SURFACE AREAS FOR CHEMOTHERAPY DOSING ARE ASSOCIATED WITH INFERIOR SURVIVAL IN MALE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A STUDY OF 658 R-CHOP TREATED PATIENTS.

EHA Library, Peter Svenssen Munksgaard, 99769

18-F FDG PET/CT VERSUS BONE MARROW BIOPSY FOR ASSESSMENT BONE MARROW INVOLVEMENT IN PATIENTS WITH NON-HODGKIN LYMPHOMA

EHA Library, Donka Vassileva, 99770

HIGH THROUGHPUT TCR SEQUENCING PROVIDES ADDED VALUE IN THE DIAGNOSIS OF CUTANEOUS T-CELL LYMPHOMA

EHA Library, Ilan Kirsch, 99771

COMPARISON OF THREE DIFFERENT PRIMING REGIMENS BASED ON IDARUBICIN, ACLACINOMYCIN OR PIRARUBICIN FOR REFRACTORY/RELAPSE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Kourong Miao, 99772

HISTOLOGICAL DISTRIBUTION, TREATMENT AND PROGNOSIS OF PERIPHERAL T-CELL LYMPHOMAS: AN ANALYSIS OF 505 PATIENTS IN TAIWAN

EHA Library, Hsiao-Wen Kao, 99773

LONG-TERM RESULTS OF TREATMENT OF DIFFUSE LARGE CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C (DLBCL+C).

EHA Library, sergey lepkov, 99774

INTERIM 18F-FGD PET/CT MAY NOT PREDICT THE OUTCOME IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS TREATED WITH INTENSIVE METHOTREXATE AND CYTARABINE

EHA Library, Jae-Cheol Jo, 99775

APPLICATION OF SYSTEMS PHARMACOLOGY MODELING FOR EVALUATION OF THERAPIES EFFECT ON BLAST DYNAMICS IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Antonina Nikitich, 99776

C-MYC AND BCL2 TRANSLOCATION FREQUENCY IN DIFFUSE LARGE B CELL LYMPHOMAS

EHA Library, Bahar Akkaya, 99777

THE D816V C-KIT MUTATION HAS HIGHER ABILITY OF JAK-STAT AND SRC FAMILY KINASE THAN N822K C-KIT MUTATION, AND THEREFORE PROLIFERATION ACTIVITY IS HIGH IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA.

EHA Library, Ikuko Omori, 99778

FREQUENCY AND PROGNOSTIC RELEVANCE OF HTERT SPLICED VARIANTS IN AML.

EHA Library, Paolo Bernasconi, 99779

COMPLEMENTARY DYNAMIC BH3 PROFILES PREDICT INDUCTION OF APOPTOSIS BY THE MULTI-KINASE INHIBITOR TG02 IN COMBINATION WITH THE BH3 MIMETIC ABT-199 IN AML CELLS

EHA Library, Monica Pallis, 99780

LONG-TERM OUTCOME OF ADULTS WITH FIRST-RELAPSED OR REFRACTORYSYSTEMIC ALCL: A LYSA STUDY

EHA Library, Alexandre Morel, 99781

THE SYK INHIBITORS R788, R406 AND P505-15 COUNTERACT NEOPLASTIC CELL SURVIVAL AND SYNERGIZE WITH MIDOSTAURIN IN PRODUCING GROWTH ARREST IN AML CELL LINES AND PRIMARY AML BLASTS

EHA Library, René Gaupmann, 99782

NEXT GENERATION SEQUENCING OF MYELOID MALIGNANCIES IDENTIFIED A SPECTRUM OF NOVEL MUTATIONS IN EPIGENETIC REGULATORS – CENTER FOR INDIVIDUALIZED MEDICINE CLINIC EXPERIENCE.

EHA Library, Moussab Damlaj, 99784

A COMPREHENSIVE ANALYSIS OF ACCESSIBLE BONE MARROW PROTEINS FOR ANTIBODY-BASED THERAPY OF ACUTE MYELOID LEUKEMIA

EHA Library, Linus Angenendt, 99785

GASTROINTESTINAL TRACT POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER (PTLD) AFTER KIDNEY TRANSPLANT: A 17-YEAR BRAZILIAN SINGLE-CENTRE EXPERIENCE

EHA Library, Egyla Cavalcante, 99786

THE ROLE OF UPFRONT AUTOLOGOUS STEM CELL TRANSPLANTATION FOR HIGH-RISK PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Hyunsoo Cho, 99787

FAVORABLE OUTCOME IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA IN A SINGLE CENTRE: THE PADUA EXPERIENCE.

EHA Library, Silvia Imbergamo, 99788

TARGETED NEXT GENERATION SEQUENCING (NGS) IN PARALLEL ANALYSES OF CHILDHOOD (CAML) AND ADULT ACUTE MYELOID LEUKEMIA (AAML) PATIENTS

EHA Library, Irena Glumac, 99789

CD30 EXPRESSION IN DLBCL, INCIDENCE AND PROGNOSIS VALUE: A SINGLE-INSTITUTION EXPERIENCE.

EHA Library, Laura García-Sanchis, 99790

VSTM-V1 IS A POTENTIAL MYELOID DIFFERENTIATION ANTIGEN GENE THAT IS DOWNREGULATED IN BONE MARROW CELLS FROM PATIENTS WITH MYELOID LEUKEMIA

EHA Library, Jiao Zhou, 99791

IDENTIFICATION OF CYTOGENETIC AND MOLECULAR SUBGROUPS OF ACUTE MYELOID LEUKEMIAS SHOWING L-ASPARAGINASE IN VITRO SENSITIVITY

EHA Library, Salvatore Nicola Bertuccio, 99792

AZACITIDINE FOR THE TREATMENT OF MDS, AML AND CMML: THE SOUTH WALES (UK) EXPERIENCE

EHA Library, Ali Mahdi, 99793

MIRNA SIGNATURES ASSOCIATED WITH MOLECULAR MARKERS IN ACUTE MYELOID LEUKEMIA

EHA Library, Marta Llop, 99794

PREGNANCY MANAGEMENT IN VON WILLEBRAND'S DISEASE

EHA Library, Maria Vinogradova, 99795

EFFICACY AND SAFETY PROFILE OF RIVAROXABAN FOLLOWING HIP AND KNEE ARTHROPLASTY

EHA Library, Sheena Patel, 99796

ANALYSIS OF GENETIC POLYMORPHISMS IN DNA REPAIR GENES IN ASSOCIATION WITH ACUTE MYELOID LEUKEMIA AND ITS SPECIFIC CHROMOSOMAL ABNORMALITIES

EHA Library, Aggeliki Daraki, 99797

FAVORABLE PROGNOSTIC IMPACT OF NMP1 MUTATION IN ELDERLY PATIENTS WITH NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA

EHA Library, Marijana Virijevic, 99798

LONG TERM EFFICACY OF CONSOLIDATION TREATMENT WITH COURSES OF HIGH-DOSE CYTARABINE AND LIMITED AUTOLOGOUS PBSC SUPPORT IN A SERIES OF ADULTS WITH ACUTE MYELOID LEUKEMIA NOT AT HIGH BIOLOGICAL RISK

EHA Library, Erika Borlenghi, 99799

HIGH CURE RATE OF YOUNGER AML PATIENTS WITH FLUDARABINE, CYTARABINE AND IDARUBICINE INDUCTION AND RISK ORIENTED CONSOLIDATION: TEN- YEARS REAL LIFE EXPERIENCE

EHA Library, Paola Minetto, 99800

VITAMIN D LEVELS OF CHILDREN WITH FANCONI ANEMIA

EHA Library, Canan Albayrak, 99801

CLOFARABINE AND HIGH-DOSE CYTARABINE ARABINOSIDE (CLARA) FOR PRIMARY REFRACTORY OR RELAPSED ACUTE MYELOID LEUKAEMIA – A PROSPECTIVE FOLLOW-UP STUDY OF 60 PATIENTS

EHA Library, Harry Gill, 99802

DISTINCT EPIDEMIOLOGIC EXPOSURES AND PROGNOSTIC FACTORS FOR SURVIVAL IN OLDER ADULTS AGE ≥70 YEARS RECEIVING LOW INTENSITY THERAPY FOR ACUTE MYELOID LEUKEMIA (AML)

EHA Library, James M Foran, 99803

IDENTIFICATION OF PROGNOSTIC FACTORS RELATED TO THERAPEUTIC OUTCOMES OF CHEMOTHERAPY AND ALLOGENEIC STEM CELL TRANSPLANTATION IN 120 ACUTE MYELOID LEUKEMIA PATIENTS WITH MONOSOMAL KARYOTYPE IN KOREA

EHA Library, Hyunsoo Cho, 99804

NO INCREASE IN LEVEL OF FATIGUE AMONG LONG-TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Åsa Derolf, 99805

CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA

EHA Library, Olfa Kassar, 99806

PROGNOSATIC RISK SCORE FOR HAEMORRHAGIC EARLY DEATH IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Mirjana Mitrovic, 99807

THERAPY-RELATED ACUTE MYELOID LEUKEMIA IN ADULTS: IS AGE YOUNGER THAN 40 CLINICALLY RELEVANT?

EHA Library, Deniz Peker, 99808